Document Detail


Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand.
MedLine Citation:
PMID:  8313548     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The morning increase in asymptomatic ambulatory ischemia may be due to heightened coronary tone, increased physical activity, or both. If ambulatory ischemia is primarily due to physical activity, then alterations in the schedule of physical activity should be reflected in a corresponding alteration in the occurrence of ischemia. This study was designed to examine the relation between activity patterns and the frequency of ambulatory ischemic episodes and the effect of nadolol on these relations. METHODS AND RESULTS: A double-blind, randomized, placebo-controlled, crossover trial of nadolol versus placebo was performed in 20 patients with stable coronary artery disease. At the end of each 2-week treatment phase, patients were hospitalized for 48 hours. In the hospital, there was a regular activity day (awaken and assume normal activities at 8:00 AM) and a delayed activity day (awaken at 8:00 AM, arise at 10:00 AM, and begin normal activity at noon). Ambulatory ECG monitoring was performed throughout the hospitalization. On the regular activity day, there was a morning increase in heart rate and in the number of ischemic episodes during therapy with placebo that began at 8:00 AM. In contrast, on the delayed activity day, there was a 4-hour phase shift of the increases in heart rate and the increase in ischemic episodes (ie, at noon) corresponding to the onset of physical activities. Therapy with nadolol caused a 50% reduction in the total number of ischemic episodes (129 versus 65, placebo versus nadolol; P < .02). During nadolol therapy, there was no discernible circadian peak in the number of ischemic episodes on either activity day. During placebo treatment, 87% of ischemic episodes were preceded by an increase in heart rate > or = 5 beats per minute. Although nadolol caused a significant reduction in the total number of episodes preceded by a heart rate increase compared with placebo (99 versus 38 episodes, P < .04), this therapy was associated with a significant increase in the number of episodes not associated with a heart rate increase (15 versus 21 episodes, P < .002). CONCLUSIONS: The morning increase in ambulatory ischemic episodes is due to physical activity patterns. The majority of ischemic episodes are preceded by a heart rate increase, and it is these episodes that are primarily responsible for the morning increase in ischemia. Therapy with nadolol caused a reduction in the total number of ischemic episodes solely by reducing those episodes preceded by a heart rate increase. In contrast, nadolol caused a significant increase in the number of ischemic episodes not associated with a heart rate increase, perhaps in part because it potentiated coronary vasoconstriction.
Authors:
J D Parker; M A Testa; A H Jimenez; G H Tofler; J E Muller; J O Parker; P H Stone
Related Documents :
6137148 - Protection of ischemic rabbit myocardium by glutamic acid.
2389718 - Current technology in assessing painless and painful ischemia.
8315178 - Repetitive nocturnal arterial oxygen desaturation and silent myocardial ischemia in pat...
6206518 - Cardioprotective effects of enalapril in acute myocardial ischemia.
10366178 - Management of the older person with atrial fibrillation.
24134248 - Diagnostic value of stored electrograms in single-lead vdd systems.
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Circulation     Volume:  89     ISSN:  0009-7322     ISO Abbreviation:  Circulation     Publication Date:  1994 Feb 
Date Detail:
Created Date:  1994-03-18     Completed Date:  1994-03-18     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  604-14     Citation Subset:  AIM; IM    
Affiliation:
Cardiovascular Division, Brigham and Women's Hospital, Boston.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Ambulatory Care
Circadian Rhythm*
Coronary Disease / complications*,  drug therapy*
Double-Blind Method
Electrocardiography, Ambulatory
Female
Heart Rate
Humans
Male
Middle Aged
Myocardial Ischemia / etiology*,  physiopathology*
Nadolol / therapeutic use*
Physical Exertion*
Time Factors
Grant Support
ID/Acronym/Agency:
NCRR GCRC M01-RR-02635/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
42200-33-9/Nadolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prosta...
Next Document:  Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable...